Posterolateral Elbow Dislocation: MRI Study of Ligament and Muscle Healing (PED-MRI)

The goal of this prospective observational study is to evaluate the healing of the medial collateral ligament (MCL) and associated muscle injuries following posterolateral elbow dislocation using magnetic resonance imaging (MRI).

The main question the study aims to answer is:

* What proportion of patients with posterolateral elbow dislocation have a healed MCL at 12 months, based on MRI assessment?

The study will also assess MCL healing at 6 months and evaluate elbow pain, functional recovery, range of motion, stiffness, clinical instability, and ulnar nerve neuropathy at baseline, 6 months, and 12 months. The study will investigate whether patient characteristics and clinical factors are associated with ligament and muscle healing, persistent instability, stiffness, or functional outcomes.

Participants will undergo clinical and radiological assessments at inclusion, including evaluation of pain, elbow function, range of motion, elbow stability, and ulnar nerve symptoms. An initial MRI will be performed within 2 to 10 days after injury to document early tissue damage. Follow-up MRI and clinical assessments will be performed at 6 and 12 months.

The primary outcome will be the rate of MCL healing at 12 months, determined by qualitative MRI assessment by a radiologist. The MCL will be classified as either "Healed" or "Not healed".

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

44

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population will consist of adult patients with an acute posterolateral elbow dislocation managed at the study center. Participants will be followed prospectively for 12 months to evaluate medial collateral ligament healing and associated clinical outcomes. Participants will undergo MRI and clinical assessments to evaluate ligament injury and healing, elbow pain, functional status, range of motion, clinical instability, and ulnar nerve neuropathy.

Description

Inclusion Criteria:

  • Adult over 18 years of age.
  • Patients who had a simple dislocation of the elbow dated 15 days or less (i.e., without associated fracture) that can be reduced by closed means. Presence of a dislocation and absence of fracture(s) will be confirmed by a plain X-ray.
  • Patients who had an MRI scan after elbow dislocation.
  • Patient who has given non-opposition to this research.
  • Patient affiliated to/or beneficiary of a social security scheme.

Exclusion Criteria:

  • Adult over 75 years old.
  • Patient refusing to participate in the study.
  • Pregnant and breastfeeding women.
  • Polytraumatized patients.
  • Recurrent or open dislocation.
  • Additional traumatic injuries to the affected arm.
  • Surgical intervention for the treatment of the initial elbow dislocation prior to study inclusion.
  • Impaired elbow function prior to trauma (i.e., stiff or painful elbow or neurological disorder such as inflammatory arthritis).
  • Previous operations or fractures involving the elbow.
  • Patients who have been previously diagnosed with an upper limb neuromuscular disease.
  • Protected patient: an adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Posterolateral Elbow Dislocation

Participants with posterolateral elbow dislocation will undergo prospective MRI and clinical follow-up to evaluate medial collateral ligament and muscle healing and their relationship with elbow pain, function, range of motion, instability, and ulnar nerve neuropathy.

MRI, radiographs, clinical examination, and physiotherapy are study procedures/assessments rather than interventions being assigned by the study.

The protocol does mention physiotherapy for relocation of the elbow. Because this is standard of care and not an experimental treatment, I would not enter it as a study intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medial Collateral Ligament (MCL) Healing Assessed by MRI
Time Frame: 12 months after elbow dislocation

Healing of the medial collateral ligament (MCL) will be assessed using magnetic resonance imaging (MRI). A radiologist will perform a qualitative assessment based on direct radiological signs of ligament tear. The MCL will be classified as either "Healed" or "Not healed." The primary outcome will be the proportion of participants classified as having a healed MCL at 12 months.

12 months after elbow dislocation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Medial Collateral Ligament (MCL) Healing at 6 Months
Time Frame: 6 months after elbow dislocation

MCL healing will be assessed by MRI using qualitative radiological analysis. The MCL will be classified as "Healed" or "Not healed".

6 months after elbow dislocation
Elbow Pain
Time Frame: Baseline, 6 months, and 12 months

Elbow pain will be assessed using a Visual Analog Scale (VAS) ranging from 1 to 10, with higher scores indicating greater pain.

Baseline, 6 months, and 12 months
Elbow Functional Outcome
Time Frame: Baseline, 6 months, and 12 months

Elbow function will be assessed using the Mayo Elbow Performance Score (MEPS).

Baseline, 6 months, and 12 months
Elbow Range of Motion and Stiffness
Time Frame: Baseline, 6 months, and 12 months

Elbow stiffness will be assessed by measuring flexion and extension range of motion during clinical examination using a goniometer.

Baseline, 6 months, and 12 months
Clinical Elbow Instability
Time Frame: Baseline, 6 months, and 12 months

Elbow instability will be assessed clinically for valgus, varus, and posterolateral rotatory instability using the valgus stress test, varus stress test, moving milking maneuver, and posterolateral rotatory drawer test.

Baseline, 6 months, and 12 months
Incidence of Ulnar Nerve Neuropathy
Time Frame: Baseline, 6 months, and 12 months

The incidence of ulnar nerve neuropathy will be assessed clinically and coded dichotomously as present or absent.

Baseline, 6 months, and 12 months
Risk Factors for Ligament and Muscle Healing and Clinical Outcomes
Time Frame: Baseline through 12 months

Baseline demographic, medical, lifestyle, occupational, sports-related, and clinical characteristics will be analyzed as potential risk factors for ligament and muscle healing, persistent instability, elbow stiffness, and functional outcomes. Variables will include age, sex, body mass index (BMI), comorbidities, tobacco and alcohol use, occupation including manual work, overhead athlete status, associated injuries, and ongoing treatments.

Baseline through 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Pierre Laumonerie, Clinique Jouvenet

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2027

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2028

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • COS-RGDS-2024-12-017-P-LAUMONE
  • 2025-A02430-49 (Other Identifier: ID-RCB)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.